Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPH

• Status: Completed
• Trial end date: 2022-12-01
• Target enrollment: 0
• Participant gender: Male

Summary

Single dose versus double dose tamsulosin in Management of Moderate and severe lower urinary tract symptoms due to benign prostatic hyperplasia

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Menoufia University
• Treatments: Tamsulosin

Criteria

Inclusion Criteria:

• age more than 50 years

• moderate to severe lower urinary tract symptoms

Exclusion Criteria:

• prostatic cancer

• urethral stricture

• prostate surgery

• Neurogenic bladder